Showing results (701-710 of 852) with videos related to
Sort By:
Pageof 86
Neuroimage|October 1, 2005
Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhoodLaurent Hermoye, Christine Saint-Martin, Guy Cosnard, et al.Basic Research in Cardiology|November 15, 2022
InsP3R-RyR Ca2+ channel crosstalk facilitates arrhythmias in the failing human ventricleXin Jin, Matthew Amoni, Guillaume Gilbert, et al.Journal of Assisted Reproduction and Genetics|January 22, 2022
Human germline nuclear transfer to overcome mitochondrial disease and failed fertilization after ICSIMaoxing Tang, Annekatrien Boel, Noemi Castelluccio, et al.Plos Neglected Tropical Diseases|October 3, 2015
Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort StudyErmias Diro, Koert Ritmeijer, Marleen Boelaert, et al.Clinical and Vaccine Immunology : CVI|March 13, 2015
Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and PreventionJordan K Kyongo, Tania Crucitti, Joris Menten, et al.Annals of Neurology|October 1, 2016
Charcot-Marie-Tooth disease type 2G redefined by a novel mutation in LRSAM1Kristien Peeters, Paulius Palaima, Ana L Pelayo-Negro, et al.Nature Communications|July 24, 2025
Restriction of Ku translocation protects telomere endsStefano Mattarocci, Sonia Baconnais, Florian Roisné-Hamelin, et al.RSC Medicinal Chemistry|January 30, 2026
CNS penetrant TEAD1,2,4 inhibitor MSC-4070 derived from phenotypic screening hit optimizationTimo Heinrich, Carl Petersson, Jakub Gunera, et al.Pediatric Transplantation|March 20, 2019
Novel insights into the assessment of risk of upper gastrointestinal bleeding in decompensated cirrhotic childrenNicolas Bonnet, Jérôme Paul, Thibault Helleputte, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971M J van den Bent, M J B Taphoorn, A A Brandes, et al.Pageof 86